Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2026 12:02 ET | Source: Molecure SA

Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)

Molecure's Phase II KITE trial for OATD-01 in pulmonary sarcoidosis will continue without protocol changes following a positive IDMC review.
August 03, 2026 10:32 ET | Source: Virtual Investor Conferences

Connecting Excellence Group to Present at the OTCQB Virtual Investor Conference on 6 August 2026

LEEDS, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- XCE Connecting Excellence Group PLC (AQSE: XCE | OTCQB: XCELF) ("XCE" or the "Company"), the international executive recruitment business...
August 03, 2026 08:35 ET | Source: Virtual Investor Conferences

Sparc Technologies to Present at the OTCQB Virtual Investor Conference on August 6th

ADELAIDE, Australia, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Sparc Technologies Ltd (ASX: SPN | FRA: NLR | OTCQB: SPTCF), a company focused on commercializing technology solutions that enhance...
August 03, 2026 07:38 ET | Source: Curium

Curium Announces Definitive Agreement to Merge with Lantheus

$8B Curium-Lantheus deal creates a global radiopharmaceutical leader, expanding reach across oncology, neurology and cardiology in 70+ countries.
August 03, 2026 07:31 ET | Source: Lantheus Holdings, Inc.

Curium Announces Definitive Agreement to Merge with Lantheus

Strategic transaction would bring Curium's theranostics portfolio and global manufacturing platform together with Lantheus’ complementary U.S. radiodiagnostics business Total transaction...
August 03, 2026 05:00 ET | Source: BioNTech SE

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

Mainz, Germany, August 3, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that its Supervisory Board has appointed Guido Oelkers, Ph.D., to the...
August 02, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

They appointed a New CCO and CBO to highlight their commitment to US commercialization
August 02, 2026 15:13 ET | Source: Predictive Discovery Limited

Quartalsbericht über die Geschäftstätigkeit für den Zeitraum bis zum 30. Juni 2026

QUEBEC, Aug. 02, 2026 (GLOBE NEWSWIRE) -- Predictive Discovery Limited (ASX:PDI, TSX:PDI) („PDI“ oder das „Unternehmen“) veröffentlicht seinen Quartalsbericht für den am 30. Juni 2026 endenden...
July 31, 2026 17:01 ET | Source: Vitalist Inc.

Vitalist Inc. Appoints Antonio "Tony" Natale to Board of Directors

Vitalist Inc. appoints Antonio "Tony" Natale to its Board of Directors, effective August 1, 2026
July 31, 2026 06:59 ET | Source: Perella Weinberg Partners Group LP

Perella Weinberg Reports Second Quarter 2026 Results

Financial Overview - Second Quarter Revenues of $157 Million, Up 1% From a Year AgoGAAP Pre-Tax Income of $6 Million, Adjusted Pre-Tax Income of $27 MillionGAAP Diluted EPS of $0.06, Adjusted EPS of...